iRhythm Holdings, Inc. (IRTC)
Data as of , from SEC Form 4 filings.
See up to 3 months of IRTC. The 7-day demo opens the 1M and 3M ranges and puts IRTC on your watchlist.
Start 7-day demoLatest IRTC insider trades
About iRhythm Holdings, Inc. (IRTC)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
- San Francisco, CA
- 2,400
- 2016
- XNAS
IRTC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 59,724 | $7.43M |
| Grant or award | 5 | 99,007 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IRTC insider transactions (Form 4)
4083 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sumi Shrishrimal - Officer | Grant or award | Common Stock | 73 footnote F1 | $119.55 | $9K | |
| ||||||
 Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 1,585 footnote F1 | $174.38 footnote F4 | $276K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 1,300 footnote F1 | $174.94 footnote F5 | $227K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 637 footnote F1 | $175.96 footnote F6 | $112K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 89 footnote F1 | $177.85 | $16K | |
| Abhijit Y. Talwalkar - Director | Option exercise | Employee Stock Option (right to buy) | 5,312 | $10.71 | $57K | |
| Abhijit Y. Talwalkar - Director | Option exercise | Common Stock | 5,312 footnote F1 | $10.71 | $57K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 1,479 footnote F1 | $172.32 footnote F2 | $255K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 222 footnote F1 | $172.83 footnote F3 | $38K | |
| ||||||
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 14,059 footnote F1 | $182.94 | $2.57M | |
| ||||||
| Daniel G. Wilson - Officer | Open-market sale | Common Stock | 8,000 footnote F1 | $207.44 | $1.66M | |
| ||||||
| Daniel G. Wilson - Officer | Open-market sale | Common Stock | 5,000 | $175.00 | $875K | |
| Daniel G. Wilson - Officer | Open-market sale | Common Stock | 737 | $167.28 | $123K | |
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 653 | $167.12 | $109K | |
 Marc Wade Rosenbaum - Officer | Open-market sale | Common Stock | 226 | $158.93 | $36K | |
| Abhijit Y. Talwalkar - Director | Option exercise | Common Stock | 5,312 | $10.71 | $57K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 3,183 | $157.57 | $502K | |
| Abhijit Y. Talwalkar - Director | Open-market sale | Common Stock | 2,129 | $158.68 | $338K | |
| Abhijit Y. Talwalkar - Director | Option exercise | Employee Stock Option (right to buy) | 5,312 | $0.00 | - | |
 Chad Patterson - Officer | Open-market sale | Common Stock | 2,555 | $158.97 | $406K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 8,726 | $158.85 | $1.39M | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 9,775 | $160.06 | $1.56M | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 4,905 | $160.73 | $788K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 1,600 | $161.92 | $259K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 1,514 | $163.30 | $247K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 3,174 | $163.93 | $520K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 306 | $165.00 | $50K | |
| Mervin Smith - Officer | Open-market sale | Common Stock | 616 | $164.36 | $101K | |
| Chad Patterson - Officer | Open-market sale | Common Stock | 2,707 | $164.36 | $445K | |
 Kevin C. Oboyle - Director | Grant or award | Common Stock | 2,035 | $0.00 | - | |
 Karen K. McGinnis - Director | Grant or award | Common Stock | 2,035 | $0.00 | - | |
| Minang Turakhia - Officer | Open-market sale | Common Stock | 1,420 | $145.41 | $206K | |
| Sean Clinton Freeman - Officer | Grant or award | Common Stock | 6,761 | $0.00 | - | |
| Mark J. Rubash - Director | Grant or award | Common Stock | 1,358 | $0.00 | - | |
| Ralph Snyderman - Director | Grant or award | Common Stock | 1,358 | $0.00 | - | |
| Daniel G. Wilson - Officer | Grant or award | Common Stock | 5,701 | $0.00 | - | |
| Patrick Michael Murphy - Officer | Open-market sale | Common Stock | 2,492 | $85.89 | $214K | |
| Abhijit Y. Talwalkar - Director | Open-market purchase | Common Stock | 6,664 | $75.16 | $501K | |
| Quentin S. Blackford - Officer | Grant or award | Common Stock | 280 | $74.98 | $21K | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 16,145 | $77.41 | $1.25M | |
Recent IRTC Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
IRTC insider trading FAQ
What is the latest insider trade for IRTC?
iRhythm Holdings, Inc. (IRTC) had 9 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for IRTC runs to 83 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IRTC stock?
No insider purchases of IRTC were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling IRTC stock?
9 insider sales of IRTC were filed in the last 90 days, totaling $7.43M.
Where can I see IRTC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IRTC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel G. Wilson view on EDGAR
- - Quentin S. Blackford view on EDGAR
- - Patrick Michael Murphy view on EDGAR
- - Chad Patterson view on EDGAR
- - Sumi Shrishrimal view on EDGAR
- - Minang Turakhia view on EDGAR
- - Mervin Smith view on EDGAR
- - Julianne Rodda view on EDGAR
- - Chad Patterson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IRTC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IRTC with a 7-day demo
- IRTC on your watchlist
- Every IRTC Form 4 filing on record
- Up to 3 months of IRTC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
